185 related articles for article (PubMed ID: 18794420)
1. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling.
Fernandez-Ranvier GG; Weng J; Yeh RF; Khanafshar E; Suh I; Barker C; Duh QY; Clark OH; Kebebew E
Arch Surg; 2008 Sep; 143(9):841-6; discussion 846. PubMed ID: 18794420
[TBL] [Abstract][Full Text] [Related]
2. Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13.
Fernandez-Ranvier GG; Weng J; Yeh RF; Shibru D; Khafnashar E; Chung KW; Hwang J; Duh QY; Clark OH; Kebebew E
World J Surg; 2008 May; 32(5):873-81. PubMed ID: 18324346
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.
Patterson EE; Holloway AK; Weng J; Fojo T; Kebebew E
Cancer; 2011 Apr; 117(8):1630-9. PubMed ID: 21472710
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors.
Rechache NS; Wang Y; Stevenson HS; Killian JK; Edelman DC; Merino M; Zhang L; Nilubol N; Stratakis CA; Meltzer PS; Kebebew E
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1004-13. PubMed ID: 22472567
[TBL] [Abstract][Full Text] [Related]
5. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.
Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A
Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361
[TBL] [Abstract][Full Text] [Related]
8. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.
Giordano TJ; Thomas DG; Kuick R; Lizyness M; Misek DE; Smith AL; Sanders D; Aljundi RT; Gauger PG; Thompson NW; Taylor JM; Hanash SM
Am J Pathol; 2003 Feb; 162(2):521-31. PubMed ID: 12547710
[TBL] [Abstract][Full Text] [Related]
9. Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.
Liu-Chittenden Y; Patel D; Gaskins K; Giordano TJ; Assie G; Bertherat J; Kebebew E
J Clin Endocrinol Metab; 2016 Sep; 101(9):3345-52. PubMed ID: 27336360
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J
Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.
Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E
Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045
[TBL] [Abstract][Full Text] [Related]
15. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
[TBL] [Abstract][Full Text] [Related]
16. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
18. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
Subramanian C; Cohen MS
Surgery; 2022 Jan; 171(1):119-129. PubMed ID: 34353633
[TBL] [Abstract][Full Text] [Related]
20. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]